Patent · US Active

HDAC8 inhibitors for treating cancer

US10308596B2 · kind B2 · utility

1Cited by
5References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 11, 2016
Grant dateJun 4, 2019
Priority date—
Expiry dateMar 8, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/24
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein, inter alia, are compound and methods of treating cancer by inhibiting HDAC8.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.